Article: CytoDyn Shares Trading and GlaxoSmithKline's Rotavirus Vaccine Candidate Shown Effective Against Rotavirus Disease.

M2 PRESSWIRE-6 January 2006-US Financial Network: CytoDyn Shares Trading and GlaxoSmithKline's Rotavirus Vaccine Candidate Shown Effective Against Rotavirus Disease(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:06012006

City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU) The common stock of CytoDyn, Inc. (OTCBB: CYDY) is trading on the Over the Counter Bulletin Board under the symbol CYDY. The company was recently featured on the Albuquerque Journal Newspaper (www.abqjournal.com) discussing Cytolin. "CytoDyn Inc., a publicly traded bio-tech firm headquartered in Santa Fe, developed Cytolin, a drug that significantly ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!